| scholarly article | Q13442814 |
| P2093 | author name string | Patrick Garnero | |
| P2860 | cites work | Homocysteine levels and the risk of osteoporotic fracture | Q28261532 |
| Homocysteine as a predictive factor for hip fracture in older persons | Q28261544 | ||
| PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures | Q28505640 | ||
| Influence of nonenzymatic glycation on biomechanical properties of cortical bone | Q31967796 | ||
| In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption | Q33885263 | ||
| Markers of bone turnover for the prediction of fracture risk | Q34148402 | ||
| Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis | Q34325799 | ||
| Identification of osteopenic women at high risk of fracture: the OFELY study. | Q34450708 | ||
| Effects of non-enzymatic glycation on cancellous bone fragility. | Q35429093 | ||
| Non-enzymatic glycation alters microdamage formation in human cancellous bone. | Q35429148 | ||
| Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral | Q35590473 | ||
| Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links | Q35809570 | ||
| The role of the collagen matrix in skeletal fragility | Q36830308 | ||
| Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH study | Q37194922 | ||
| Pentosidine and increased fracture risk in older adults with type 2 diabetes | Q37257534 | ||
| Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. | Q37323596 | ||
| The multiple facets of periostin in bone metabolism | Q37981902 | ||
| Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. | Q38700889 | ||
| Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. | Q39735458 | ||
| A Collagen Defect in Homocystinuria | Q40372811 | ||
| Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization. | Q40476993 | ||
| Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK). | Q40636638 | ||
| Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes | Q41342582 | ||
| The relative contributions of non-enzymatic glycation and cortical porosity on the fracture toughness of aging bone | Q42161678 | ||
| Regulation of lysyl oxidase by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells | Q42815294 | ||
| Pre- and post-translational regulation of lysyl oxidase by transforming growth factor-beta 1 in osteoblastic MC3T3-E1 cells | Q42818962 | ||
| Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential | Q42995624 | ||
| Association between collagen cross-links and trabecular microarchitecture properties of human vertebral bone | Q43260010 | ||
| Age-related changes in the collagen network and toughness of bone | Q44058103 | ||
| Cross-link profile of bone collagen correlates with structural organization of trabeculae | Q44058122 | ||
| Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links | Q44125426 | ||
| Effects of elevated circulating IGF-1 on the extracellular matrix in "high-growth" C57BL/6J mice | Q44777010 | ||
| A crosslinked cofactor in lysyl oxidase: redox function for amino acid side chains. | Q45946202 | ||
| Urinary levels of pentosidine and the risk of fracture in postmenopausal women: the OFELY study. | Q46022308 | ||
| Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs | Q46277861 | ||
| Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls | Q46281109 | ||
| Effects of preexisting microdamage, collagen cross-links, degree of mineralization, age, and architecture on compressive mechanical properties of elderly human vertebral trabecular bone | Q46295396 | ||
| Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. | Q46481716 | ||
| Advanced glycation end products and bone loss during aging. | Q46613220 | ||
| Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone | Q46791836 | ||
| Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes | Q46832348 | ||
| Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures | Q46839982 | ||
| Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra. | Q46840159 | ||
| Reduced concentrations of collagen cross-links are associated with reduced strength of bone. | Q51039477 | ||
| Homocysteine and fracture risk in postmenopausal women: the OFELY study. | Q51102387 | ||
| Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized m | Q51536719 | ||
| Experimental Hyperhomocysteinemia Reduces Bone Quality in Rats | Q56992748 | ||
| Lysyl oxidase (LOX) down-regulation by TNFα: A new mechanism underlying TNFα-induced endothelial dysfunction | Q60923974 | ||
| Nonmineralized and mineralized compartments of bone: the role of pyridinoline in nonmineralized collagen | Q71786577 | ||
| Lysyl oxidase: Evidence that pyridoxal phosphate is a cofactor | Q72543150 | ||
| Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles | Q73106325 | ||
| Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region | Q73201770 | ||
| Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1-34) for 18 months | Q73212250 | ||
| Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone | Q73673396 | ||
| Single-column high-performance liquid chromatographic-fluorescence detection of immature, mature, and senescent cross-links of collagen | Q73842432 | ||
| Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria | Q73956052 | ||
| Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study | Q74091282 | ||
| Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study | Q75363746 | ||
| Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength | Q78109893 | ||
| Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women | Q79219036 | ||
| Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae | Q79863234 | ||
| Alpha CTX as a biomarker of skeletal invasion of breast cancer: immunolocalization and the load dependency of urinary excretion | Q79885327 | ||
| Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies | Q81230244 | ||
| Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations | Q82910381 | ||
| Cathepsin K preferentially solubilizes matured bone matrix | Q84090869 | ||
| Urinary pentosidine improves risk classification using fracture risk assessment tools for postmenopausal women | Q84578362 | ||
| P304 | page(s) | 182 | |
| P577 | publication date | 2012-09-19 | |
| P1433 | published in | BoneKEy reports | Q27724456 |
| P1476 | title | The contribution of collagen crosslinks to bone strength | |
| P478 | volume | 1 |
| Q53056451 | A highly sensitive electrochemical biosensor based on AuNP-modified gold electrodes for selective determination of serum levels of crosslaps. |
| Q38434317 | A look behind the scenes: the risk and pathogenesis of primary osteoporosis |
| Q50992204 | Aging Versus Postmenopausal Osteoporosis: Bone Composition and Maturation Kinetics at Actively-Forming Trabecular Surfaces of Female Subjects Aged 1 to 84 Years. |
| Q35807492 | Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent? |
| Q51034894 | Assessment of collagen quality associated with non-enzymatic cross-links in human bone using Fourier-transform infrared imaging. |
| Q37113961 | Bone mechanical properties and changes with osteoporosis |
| Q38364893 | Bone's Material Constituents and their Contribution to Bone Strength in Health, Disease, and Treatment. |
| Q40679886 | Changes in Structural-Mechanical Properties and Degradability of Collagen during Aging-associated Modifications |
| Q90222489 | Collagen-infilled 3D printed scaffolds loaded with miR-148b-transfected bone marrow stem cells improve calvarial bone regeneration in rats |
| Q35925095 | Do Non-collagenous Proteins Affect Skeletal Mechanical Properties? |
| Q36372679 | Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties |
| Q53215245 | Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta. |
| Q46282873 | Fourier transform Infrared spectroscopic characterization of mineralizing type I collagen enzymatic trivalent cross-links |
| Q52899898 | Identification of Pyridinoline Trivalent Collagen Cross-Links by Raman Microspectroscopy. |
| Q27010190 | Improvement of skeletal fragility by teriparatide in adult osteoporosis patients: a novel mechanostat-based hypothesis for bone quality |
| Q41778121 | Influence of cross-link structure, density and mechanical properties in the mesoscale deformation mechanisms of collagen fibrils |
| Q64285306 | Inhibition of vascular endothelial growth factor in young adult mice causes low bone blood flow and bone strength with no effect on bone mass in trabecular regions |
| Q27025945 | Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects |
| Q37049360 | Modeling the Mechanical Consequences of Age-Related Trabecular Bone Loss by XFEM Simulation |
| Q47830778 | Periostin and its interacting proteins in the construction of extracellular architectures. |
| Q47584948 | Periostin function in communication with extracellular matrices |
| Q47382499 | Periostin in cardiovascular disease and development: a tale of two distinct roles |
| Q38942134 | Post-yield and failure properties of cortical bone |
| Q90307520 | Reversible Covalent End-Capping of Collagen Model Peptides |
| Q37119404 | Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis |
| Q33869676 | The association between the baseline bone resorption marker CTX and incident dysglycemia after 4 years |
| Q28068373 | The role of integrins in TGFβ activation in the tumour stroma |
Search more.